spiperone has been researched along with Craniopharyngioma in 1 studies
Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.
Craniopharyngioma: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to define whether assessment of the uptake of [18F]fluoro-ethyl-spiperone (FESP) with positron emission tomography (PET) could be helpful for the differential diagnosis of pituitary adenomas and other parasellar lesions, and for establishing the appropriate therapeutic approach." | 7.69 | Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [18F]fluoro-ethyl-spiperone. ( Bettinardi, V; Del Sole, A; Fazio, F; Giovanelli, M; Losa, M; Lucignani, G; Matarrese, M; Moresco, RM; Mortini, P, 1997) |
| " The aim of this study was to define whether assessment of the uptake of [18F]fluoro-ethyl-spiperone (FESP) with positron emission tomography (PET) could be helpful for the differential diagnosis of pituitary adenomas and other parasellar lesions, and for establishing the appropriate therapeutic approach." | 3.69 | Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [18F]fluoro-ethyl-spiperone. ( Bettinardi, V; Del Sole, A; Fazio, F; Giovanelli, M; Losa, M; Lucignani, G; Matarrese, M; Moresco, RM; Mortini, P, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lucignani, G | 1 |
| Losa, M | 1 |
| Moresco, RM | 1 |
| Del Sole, A | 1 |
| Matarrese, M | 1 |
| Bettinardi, V | 1 |
| Mortini, P | 1 |
| Giovanelli, M | 1 |
| Fazio, F | 1 |
1 other study available for spiperone and Craniopharyngioma
| Article | Year |
|---|---|
Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [18F]fluoro-ethyl-spiperone.
Topics: Adenoma; Adolescent; Aged; Craniopharyngioma; Diagnosis, Differential; Female; Fluorine Radioisotope | 1997 |